Soon Kil Ahn Selected Research

methyl- 4- (3- chloro- 4- methoxybenzylamino)- 8- (2- hydroxyethyl)- 7- methoxyquinazolin- 6- ylmethylcarbamate

1/2010

Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soon Kil Ahn Research Topics

Disease

6	Neoplasms (Cancer) 08/2017 - 09/2010
2	Insulin Resistance 09/2018 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 09/2018 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2018 - 01/2015
2	Melanoma (Melanoma, Malignant) 08/2017 - 07/2012
2	Erectile Dysfunction 01/2010 - 12/2008
1	Body Weight (Weight, Body) 09/2018
1	Colorectal Neoplasms (Colorectal Cancer) 08/2017
1	Infections 03/2016
1	Hypertension (High Blood Pressure) 01/2015
1	Glucose Intolerance 01/2015
1	Dyslipidemias (Dyslipidemia) 01/2015
1	Abdominal Obesity 01/2015
1	Glioma (Gliomas) 05/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2007
1	Septic Shock (Toxic Shock Syndrome) 02/2006
1	Endotoxemia 02/2006

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 09/2018 - 07/2012
2	3-methyladenineIBA 03/2016 - 07/2012
2	Protein Kinases (Protein Kinase)IBA 01/2013 - 01/2012
2	N- ((3- (3- 9H- purin- 6- yl)pyridin- 2- ylamino)- 2,4- difluorophenyl)furan- 3- sulfonamideIBA 07/2012 - 01/2012
2	ProdrugsIBA 11/2010 - 09/2010
2	Tubulin ModulatorsIBA 11/2010 - 09/2010
2	Valine (L-Valine)FDA Link 11/2010 - 09/2010
1	Blood Glucose (Blood Sugar)IBA 09/2018
1	LipidsIBA 09/2018
1	INU-101IBA 09/2018
1	Protein Isoforms (Isoforms)IBA 08/2017
1	INU-152IBA 08/2017
1	Beclin-1IBA 03/2016
1	Small Interfering RNA (siRNA)IBA 03/2016
1	DNA (Deoxyribonucleic Acid)IBA 03/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2015
1	GlucocorticoidsIBA 01/2015
1	Hormones (Hormone)IBA 01/2015
1	4- (1- ((2- fluoro- N- methylphenylsulfonamido)methyl)cyclopropanecarboxamido)adamantane- 1- carboxamideIBA 01/2015
1	Gentian Violet (Violet, Crystal)FDA Link 05/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2014
1	Sorafenib (BAY 43-9006)FDA Link 01/2013
1	Proto-Oncogene Proteins B-rafIBA 07/2012
1	Amino Acids FDA Link 11/2010
1	N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamideIBA 09/2010
1	methyl- 4- (3- chloro- 4- methoxybenzylamino)- 8- (2- hydroxyethyl)- 7- methoxyquinazolin- 6- ylmethylcarbamateIBA 01/2010
1	QuinazolinesIBA 12/2008
1	Phosphodiesterase 5 InhibitorsIBA 12/2008
1	EthersIBA 03/2007
1	higenamine (norcoclaurine)IBA 02/2006

Therapy/Procedure

1	Oral Administration 09/2018
1	Therapeutics 12/2008